Lobbying disclosure profile
Pharmaceutical Services
This profile groups public LDA.gov disclosure records connected through shared filings, clients, registrants, lobbyists, issue areas, and bill references. It is source-attributed research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.
HR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
Open LDA filing sourceHR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
Open LDA filing sourceHR 405-EMSSA; Act; H.R. 3164, S. 2464, Equitable Community Access to Pharmacists Act; MFN Drug pricing issues; 2026 Medicare Physician FeeSchedule Proposed Rule.
Open LDA filing source